Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort study

This study explores the impact of interferon-free therapies on hepatitis C virus related hepatocellular carcinoma at a population level.

Competing risk bias in prognostic models predicting hepatocellular carcinoma occurrence: impact on clinical decision making

The goal of this study was to quantify the bias in estimating risk of hepatocellular carcinoma for patients with cirrhosis and cured hepatitis C.

Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured hepatitis C infection

We conducted an external validation of six HCC prediction models for UK patients with cirrhosis HCV virological cure.

Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study

We examined the impact of the introduction of direct-acting antiviral (DAA) therapies on hepatitis C related decompensated cirrhosis (DC) through analysis of population-based data from Scotland.